GoodRx has seen growth in pharma solutions like Biosimilar Humira and is working on maximizing value for shareholders. Despite retail pharmacy challenges, their value proposition remains strong. They are focused on direct contracts, brand programs, and e-commerce to drive growth amidst the changing landscape.